NGM Biopharmaceuticals, Inc. (NGM)
Apr 5, 2024 - NGM was delisted (reason: acquired by The Column Group)
1.540
-0.020 (-1.28%)
Last trade price
NGM Biopharmaceuticals Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$3.68
Upside
+138.96%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 12, 2024 |
| TD Cowen | TD Cowen | Buy → Hold Downgrades $4 → $1.55 | Buy → Hold | Downgrades | $4 → $1.55 | +0.65% | Feb 28, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $7 → $3.5 | Strong Buy | Maintains | $7 → $3.5 | +127.27% | Nov 22, 2023 |
| Citigroup | Citigroup | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +289.61% | May 3, 2023 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +354.55% | Mar 30, 2023 |
| Raymond James | Raymond James | Buy Maintains $4 → $6 | Buy | Maintains | $4 → $6 | +289.61% | Nov 4, 2022 |
| Cowen & Co. | Cowen & Co. | Buy Maintains $32 → $9 | Buy | Maintains | $32 → $9 | +484.42% | Oct 18, 2022 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $29 → $4 | Strong Buy → Hold | Downgrades | $29 → $4 | +159.74% | Oct 18, 2022 |
| Raymond James | Raymond James | Strong Buy → Buy Downgrades $42 → $4 | Strong Buy → Buy | Downgrades | $42 → $4 | +159.74% | Oct 18, 2022 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 17, 2022 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 17, 2022 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $35 → $29 | Strong Buy | Maintains | $35 → $29 | +1,783.12% | Oct 7, 2022 |
| Jefferies | Jefferies | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +1,523.38% | Jul 20, 2022 |
| Raymond James | Raymond James | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Nov 5, 2021 |
| BMO Capital | BMO Capital | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 17, 2021 |
| Raymond James | Raymond James | Buy → Strong Buy Upgrades n/a | Buy → Strong Buy | Upgrades | n/a | n/a | Sep 13, 2021 |
| Raymond James | Raymond James | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 6, 2021 |
| Raymond James | Raymond James | Strong Buy → Buy Downgrades n/a | Strong Buy → Buy | Downgrades | n/a | n/a | May 24, 2021 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Mar 5, 2021 |
| Raymond James | Raymond James | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Mar 5, 2021 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Aug 13, 2020 |